Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 10002316 was granted and assigned to Cellular Research on June, 2018 by the United States Patent and Trademark Office. | 10002316 | June 19, 2018 | |||||||
Patent 9290808 was granted and assigned to Cellular Research on March, 2016 by the United States Patent and Trademark Office. | 9290808 | March 22, 2016 | |||||||
Patent 10933137 was granted and assigned to axsome therapeutics, inc. on March, 2021 by the United States Patent and Trademark Office. | 10933137 | March 2, 2021 | |||||||
Patent 10918722 was granted and assigned to axsome therapeutics, inc. on February, 2021 by the United States Patent and Trademark Office. | 10918722 | February 16, 2021 | |||||||
Patent 10894053 was granted and assigned to axsome therapeutics, inc. on January, 2021 by the United States Patent and Trademark Office. | 10894053 | January 19, 2021 | |||||||
Patent 10933136 was granted and assigned to axsome therapeutics, inc. on March, 2021 by the United States Patent and Trademark Office. | 10933136 | March 2, 2021 | |||||||
Patent 8835358 was granted and assigned to Cellular Research on September, 2014 by the United States Patent and Trademark Office. | 8835358 | September 16, 2014 | |||||||
Patent 10987358 was granted and assigned to axsome therapeutics, inc. on April, 2021 by the United States Patent and Trademark Office. | 10987358 | April 27, 2021 | |||||||
Patent 11013806 was granted and assigned to axsome therapeutics, inc. on May, 2021 by the United States Patent and Trademark Office. | 11013806 | May 25, 2021 | |||||||
Patent 10940153 was granted and assigned to axsome therapeutics, inc. on March, 2021 by the United States Patent and Trademark Office. | 10940153 | March 9, 2021 | |||||||
Patent 11013805 was granted and assigned to axsome therapeutics, inc. on May, 2021 by the United States Patent and Trademark Office. | 11013805 | May 25, 2021 | |||||||
Patent 11020483 was granted and assigned to axsome therapeutics, inc. on June, 2021 by the United States Patent and Trademark Office. | 11020483 | June 1, 2021 | |||||||
Patent 9290809 was granted and assigned to Cellular Research on March, 2016 by the United States Patent and Trademark Office. | 9290809 | March 22, 2016 | |||||||
Patent 11045549 was granted and assigned to axsome therapeutics, inc. on June, 2021 by the United States Patent and Trademark Office. | 11045549 | June 29, 2021 | |||||||
Patent 8946387 was granted and assigned to MacroGenics on February, 2015 by the United States Patent and Trademark Office. | 8946387 | February 3, 2015 | |||||||
Patent 11386325 was granted and assigned to Samsara Sciences on July, 2022 by the United States Patent and Trademark Office. | 11386325 | July 12, 2022 | |||||||
Patent 11301045 was granted and assigned to bertec corporation on April, 2022 by the United States Patent and Trademark Office. | 11301045 | April 12, 2022 | |||||||
Patent 10151003 was granted and assigned to Cellular Research on December, 2018 by the United States Patent and Trademark Office. | 10151003 | December 11, 2018 | |||||||
Patent 11369684 was granted and assigned to axsome therapeutics, inc. on June, 2022 by the United States Patent and Trademark Office. | 11369684 | June 28, 2022 | |||||||
Patent 9727810 was granted and assigned to Cellular Research on August, 2017 by the United States Patent and Trademark Office. | 9727810 | August 8, 2017 | |||||||
Patent 11782062 was granted and assigned to Encodia Inc. on October, 2023 by the United States Patent and Trademark Office. | 11782062 | October 10, 2023 | |||||||
Patent 10117602 was granted and assigned to bertec corporation on November, 2018 by the United States Patent and Trademark Office. | 10117602 | November 6, 2018 | |||||||
Patent 11682195 was granted and assigned to NantOmics on June, 2023 by the United States Patent and Trademark Office. | 11682195 | June 20, 2023 | |||||||
11376323 | July 5, 2022 | ||||||||
Patent 11426414 was granted and assigned to axsome therapeutics, inc. on August, 2022 by the United States Patent and Trademark Office. | 11426414 | August 30, 2022 |